JENNIFER WHITMAN: Open Payments
NPI 1861440448 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 33 payments from 14 companies in 2025. Trend: 2023 $570 · 2024 $1,011 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $327 |
| ABBVIE INC. | 6 | $197 |
| GENZYME CORPORATION | 5 | $127 |
| Journey Medical Corporation | 1 | $94 |
| UCB, Inc. | 2 | $64 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $37 |
| Lilly USA, LLC | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $25 |
Products named: CIBINQO, DUPIXENT, LITFULO, BOTOX, Bimzelx, RINVOQ, NEMLUVIO, Cabtreo.
Industry payments across MD — which companies pay providers there.
